News

Why Is Clinical Diagnostics Focused Trinity Biotech Stock Trading Higher On Tuesday?

Tuesday, Trinity Biotech plc (NASDAQ:TRIB) stock is trading higher with a session volume of 14.32 million versus the average volume of 118.9K as per data from Benzinga Pro. The company received substantial additional orders for TrinScreen HIV. Due to this demand and the scaling of production capacity, the company is now increasing its expected 2024 sales revenue for TrinScreen HIV to approximately $10 million, up from $8 million. President and Chief Executive Officer of Trinity Biotech, John Gil

Investors on Edge Before Nvidia Earnings, US Data: Markets Wrap

(Bloomberg) -- With Nvidia Corp. earnings just a day away and a heavy slate of US economic data scheduled for later in the week, there was little movement in markets on Tuesday.Most Read from BloombergNazi Bunker’s Leafy Makeover Turns Ugly Past Into Urban EyecatcherSydney Central Train Station Is Now an Architectural DestinationChicago Overcomes DNC Skeptics With Calm, Parties and SunHow the Cortiços of São Paulo Helped Shelter South America’s Largest CityWith Housing Costs High, Democrats Hone